Recall Z-2170-2012 ยท NBC Test, Natriuretic Peptide
Abbott Point Of Care Inc.
i-Stat BNP cartridges Abbott Point of Care Inc. The i-Stat BNP test is an in vitro diagnostic test for the quantitative measurement of B-type Natriuretic Peptide (BNP) in whole blood or plasma samples using EDTA as the anticoagulant. BNP measurements can be used as an aid in the diagnosis and assessment of the severity of congestive heart failure.
| Date | Aug 9, 2012 (initiated Feb 1, 2012) |
| Status | Terminated |
| Reason | The frequency of suppressed results for i-Stat cTnl, BNP and CK-MP cartridges is affected by atmospheric pressure. |
| Root cause | Device Design |
| Action | Abbott Point of Care (APOC) sent an URGENT RECALL NOTICE dated February 2012 to all affected customers via e-mail and also contacted by phone. The letter identified the product, the problem, and the action to be taken by the customer. Customers were advised that if their facility was performing testing at more than approximately 7500 feet above sea level, they should have an alternate test method available should they experience an issue. If they have forwarded any cartridges to another facility, they should provide a copy of the Urgent Recall Notice to them. For questions customers were i |
| Quantity | 1,004,200 cartridges US; 54,200 cartridges OUS |
| Distribution | Worldwide Distribution - USA including AZ and CO and internationally to Argentina, Australia, Austria, Belgium, Bolivia, Brazil, Chile, China, Colombia, Costa Rica, Dominican Republic, El Salvador, Finland, France, Georgia, Germany, Greece, Honduras, Hong Kong, India, Ireland, Italy, Korea, Kuwait |
| FDA record | Open on fda.gov |
510(k) clearances named in this recall
| K053597 | I-STAT B-TYPE NATRIURETIC PEPTIDE (BNP) I-Stat Corporation, Jul 21, 2006 |